HECHT BETH (See Remarks) sold 1.5% of their position (16.67K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $141.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/1/2026ACC: 0001652410-26-000018
Officer· See Remarks
Since Oct 2021
-16.67K
Net shares
Net seller
$141.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
16.67K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−16.67K
Price / share
$8.49
Trade value
$141.43K
% of position
1.5%
9/1/2026
1.14M→1.13M
Total
Net shares
−16.67K
Net value
-$141.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | S · Sale | −16.67K | $8.49 | $141.43K | 1.5% | 1.14M | 1.13M |
| Total | −16.67K | -$141.43K | ||||||
Derivative Transactions0
No derivative transactions reported